Pfizer Inc
NYSE: PFE
$28.86
+$0.02 (+0.1%)
Closing Price on October 23, 2024
PFE Articles
Now that we are out of the woods in the crash scenario, assuming this week is no ill omen, investors may want to know which of the big companies would start to deploy their billions and billions of...
Published:
Last Updated:
Fidelity Management & Research Company, or FMR, was among the giants which released its quarterly holdings over the most recent days. While it is always interesting to see which holdings are...
Published:
Last Updated:
Diabetes is becoming an epidemic in the U.S. and the Western World. The ties to obesity are often direct, so the potential treatments are often directly tied as well. We did a recent dig down for...
Published:
Last Updated:
MannKind Corporation (NASDAQ: MNKD) is getting hit after the company announced that it priced a secondary offering of 7,400,000 shares of its common stock. While the press release does not say what...
Published:
Last Updated:
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market....
Published:
Last Updated:
This week will mark the first crest of earnings season as we have 11 of the 30 DJIA components reporting earnings this week alone. On Tuesday, we have earnings from Caterpillar Inc. (NYSE: CAT),...
Published:
Here are some of today’s top stories affecting key drug and biotech stocks, accompanied with links through to more detailed information and analysis at BioHealthInvestor.com: New short-interest...
Published:
Short sellers upped their investments in stocks of the most prominent financial firms. Short interest in Bank of America (BAC), AIG (AIG), Wells Fargo (WFC), and Freddie Mac (FRE) all rose for the...
Published:
Last Updated:
It is hard to say whether a person is better off stopping smoking and lessening their chances of a heart attack or killing themselves. Some of the anti-smoking drugs from Pfizer (PFE) and...
Published:
Last Updated:
Reuters: California declared a financial emergency. Reuters: An SEC attorney raised concern about a Madoff report in 2004. Reuters: Auto parts supplier Lear filed for bankruptcy....
Published:
Last Updated:
Novartis AG (NYSE: NVS) shares are at session highs and well of the lows of the day in the early afternoon Thursday after Japan okayed one of the company’s human growth hormones, the first approval...
Published:
Everyone is trying to figure out who the winners and losers are likely to be under a watered-down healthcare program under the Obama administration and with a Democratic Congress. What is certain...
Published:
Reuters: The heads of the emerging markets, the so-called BRICs, held their first global summit. Reuters: Obama will be tested this week on financial reforms. Reuters: Rich nations are...
Published:
Last Updated:
We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data presentations slated to start this weekend. This is broken down...
Published:
We are just about to get the first round of abstracts from companies presenting data at this year’s American Society of Clinical Oncology meeting for 2009. At BioHealthInvestor.com we compiled a...
Published: